期刊文献+

miR-539通过抑素调控非小细胞肺癌的细胞增殖、迁移和凋亡 被引量:3

miR-539 for non-small cell lung cancer cell proliferation,migration and apoptosis by prohibitin regulation
原文传递
导出
摘要 目的:探讨miR-539通过抑素调控非小细胞肺癌(NSCLC)细胞增殖、迁移和凋亡的机制。方法:选择2019年1月至2020年1月期间武汉科技大学附属孝感医院收治的6例NSCLC手术患者作为研究对象进行回顾性分析,术中采集未实施放化疗的NSCLC标本,置于液氮中保存,提取总RNA,通过miR-539在NSCLC中靶基因的筛选确定抑素是miR-539的候选靶基因。采用反转录荧光定量聚合酶链式反应技术定量检测miR-539、抑素,CCK-8检测细胞增殖,划痕试验检测细胞迁移,流式细胞术检测细胞凋亡。比较靶向抑制抑素组、过表达miR-539组和低表达miR-539组的细胞增殖、迁移及凋亡情况检测。结果:过表达组抑素mRNA相对表达量(1.00±0.07)明显高于阴性对照组(0.20±0.02)(t=26.917,P<0.001),细胞增殖能力(4.21±1.21)较阴性对照组(8.09±0.97)降低(t=6.128,P<0.001),细胞迁移能力[(514.28±36.14)个]较阴性对照组[(1500.33±156.25)个]降低(t=15.060,P<0.001),细胞凋亡率[(53.21±7.59)%]较阴性对照组[(40.25±6.21)%]增高,(t=3.237,P=0.009)。抑制抑素组细胞增殖能力(11.32±0.36)较低表达组(9.03±0.28)和过表达组(5.69±0.08)高(F=672.994,P<0.001),细胞凋亡率[(38.56±5.24)%]较低表达组[(47.26±4.98)%]和过表达组[(58.61±6.32)%]低(F=19.735,P<0.001)。结论:抑素作为miR-539的候选靶基因,两者均可作为抑癌基因抑制癌细胞增殖、迁移,促进细胞凋亡。miR-539对NSCLC细胞增殖、迁移、凋亡的调控作用与抑素具有紧密的关系。 Objective To study miR-539 for non-small cell lung cancer(NSCLC)cell proliferation,migration and apoptosis by prohibitinregulation.Methods There were six cases of NSCLC operative patients from Xiaogan Hospital of Wuhan University of Science and Technology during the period January 2019 to January 2020 selected as subject,NSCLC samples not implement concurrent chemoradiation were collected intraoperatively and preserved in liquid nitrogen,total RNA were extracted,prohibit was candidate target genes of miR-539 while determined by miR-539 screen target genes in NSCLC.miR-539,prohibitin were used by RT-PCR technology quantitative detection,cell proliferation were detected by CCK-8,cell migration were detected by scratch test,cell apoptosis were detected by flow cytometry.The cell proliferation,migration and apoptosis among prohibitin inhibition group,over-express group,low-express group and negative control group were compared.Results The relative quantity of prohibitin in over-express group(1.00±0.07)was significantly higher than negative control group(0.20±0.02)(t=26.917,P<0.001),the cell proliferation(4.21±1.21)was significantly lower than negative control group(8.09±0.97)(t=6.128,P<0.001),the cell migration(514.28±36.14)was significantly lower than negative control group(1500.33±156.25)(t=15.060,P<0.001),the cell apoptosis rate[(53.21±7.59)%]was significantly higher than negative control group[(40.25±6.21)%](t=3.237,P=0.009).The cell proliferation of prohibitin inhibition group(11.32±0.36)was significantly higher than low-express group(9.03±0.28)and over-express group(5.69±0.08)(F=672.994,P<0.001),the cell apoptosis rate[(38.56±5.24)%]was significantly lower than low-express group[(47.26±4.98)%]and over-express group[(58.61±6.32)%](F=19.735,P<0.001).Conclusions Prohibitin can be as a candidate target genes of miR-539,both as a tumor suppressor gene transfer on promoting inhibit cancer cell proliferation,migration,promote apoptosis in NSCLC cell.
作者 钟敏华 吴展陵 李新军 涂平华 杨英 Zhong Minhua;Wu Zhanling;Li Xinjun;Tu Pinghua;Yang Ying(Department of Respiratory Medicine,Xiaogan Hospital of Wuhan University of Science and Technology,Xiaogan 432100,China;Wuhan University of Science and Technology,Wuhan 430081,China)
出处 《国际呼吸杂志》 2020年第19期1510-1515,共6页 International Journal of Respiration
基金 湖北省卫计委2018年度联合基金(WJ2018H0115)。
关键词 非小细胞肺 细胞增殖 细胞凋亡 miR-539 抑素 Carcinoma,non-small-cell lung Cell proliferationm Apoptosis miR-539 Prohibitinm
  • 相关文献

参考文献9

二级参考文献47

  • 1刘勇,梁长华,李增志,李吉.MicroRNA在原发性肝细胞肝癌发生与发展中的作用及临床意义[J].世界临床医学,2017,11(13):110-110. 被引量:1
  • 2徐林,任涛,周涯,秦安东,郑静.微小RNA-7对人肺癌95D细胞体外增殖的作用[J].肿瘤,2010,30(9):763-767. 被引量:19
  • 31998-2003年北京地区重症加强治疗病房急性呼吸窘迫综合征的临床流行病学调查[J].中国危重病急救医学,2007,19(4):201-204. 被引量:32
  • 4Kobaya~shi E, Hornicek FJ, Duan Z.[J]. Sarcoma, 2012, 2012 (2012): 359739-359742.
  • 5Jikuzono T, Kawamoto M, Yoshitake H, et al. The miR-221222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma[J]. In- ternational Journal of Ontology, 2013, 42(6): 1858-1868.
  • 6Mazeh H, Mizrahi I, Halle D, et al. Development of a mieroR- NA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples[J]. Thyroid Official Journal of the American Thyroid Association, 2011, 21(2): 111-118.
  • 7Pierlorenzo P, Rosa V, Carlo Maria C, et al. Deregulation of mi- croRNA in follicular-cell-derived human thyroid carcinomas[J]. Endt~crine-re~ated Cancer, 20tO, 17(1): 91.-104.
  • 8Santos J C, Bastos A U, Cerutti J M, et al. Correlation of MLH1 and MGMT and promoter methylation with genomic instability in patients with thyroid carcinoma[J]. Bmc Cancer, 2013, 13(4): 1-7.
  • 9Dongfeng N, Tetsuo K, Tadao N, ctal. Differential of aquaporins and its diagnostic utility in thyroid earteer[J]. Plos One, 2012, 7 (7): 5567-5574.
  • 10Lin SF, Huang YY, Lin JD, et al. Utility of a PI3KmTOR in- hibitor (NVP-BEZ235) for thyroid cancer therapy[J]. Plos One, 2012, 7(10): 46726.

共引文献71

同被引文献25

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部